Traditional HER2 testing protocols, developed for breast and gastric cancers and adopted for colorectal cancer, allow for HER2 assessment via IHC followed by reflex to in situ hybridization (ISH) for equivocal (IHC 2+) cases (36). Here, ERBB2 is linked to colorectal cancer.